Steqeyma SC — Medical Mutual

Preferred products

• Stelara SC
• Selarsdi SC
• ustekinumab-ttwe SC
• Yesintek SC

Initial criteria

• Patient age > 6 years; AND
• Medication prescribed by or in consultation with a rheumatologist or dermatologist

Reauthorization criteria

• Patient has been established on ustekinumab SC ≥6 months; AND
• Patient experienced beneficial clinical response measured by standardized disease activity indices OR
• Patient experienced improvement in ≥1 symptom (e.g., joint pain, stiffness, fatigue, swelling, function)

Approval duration

initial 6 months, reauth 1 year